Complete Up To Date Information about Reconcile .
NADA Number: 141-272 | |
| Proprietary Name |
Reconcile® |
|---|---|
| Sponsor |
Elanco Animal Health, A Division of Eli Lilly & Co. |
| Sponsor Address |
Lilly Corporate Center Room 1-23, 12420 Parklawn Drive Indianapolis, IN 46285 USA |
| Ingredients |
Fluoxetine hydrochloride |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet (chewable) |
| Drug Form |
Tablet (chewable) |
| Dispensing Status |
RX |
| Exclusivity |
New approval. |
|
Dosage Amount, Indications & Limitations |
520.980 Fluoxetine Specifications. Each chewable tablet contains 8, 16, 32, or 64 milligrams (mg) fluoxetine hydrochloride. Conditions of use Dogs Amount 1 to 2 mg per kilogram body weight once daily. Indications For the treatment of canine separation anxiety in conjunction with a behavior modification plan. Limitations Federal law restricts this drug to use by or on the order of a licensed veterinarian.
|